Exact Mass: 323.1005

Exact Mass Matches: 323.1005

Found 87 metabolites which its exact mass value is equals to given mass value 323.1005, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Tazarotenic acid

6-[2-(4,4-dimethyl-3,4-dihydro-2H-1-benzothiopyran-6-yl)ethynyl]pyridine-3-carboxylic acid

C19H17NO2S (323.098)


Tazarotenic acid is a metabolite of tazarotene. Tazarotene (marketed as Tazorac, Avage and Zorac) is a prescription topical retinoid sold as a cream or gel. This medication is approved for treatment of psoriasis, acne, and sun damaged skin (photodamage). It is commonly sold in two concentrations: 0.05\\% and 0.1\\%. Common side effects include worsening of acne, dry skin, itchiness, redness and in some cases extreme drying and cracking of skin. (Wikipedia)

   

desmethyladinazolam

{12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0²,⁶]tetradeca-1(10),3,5,8,11,13-hexaen-3-yl}methanamine

C17H14ClN5 (323.0938)


desmethyladinazolam is a metabolite of adinazolam. Adinazolam (marketed under the brand name Deracyn) is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed. (Wikipedia)

   

Ripasudil

4-Fluoro-5-[(2-methyl-1,4-diazepan-1-yl)sulphonyl]isoquinoline

C15H18FN3O2S (323.1104)


   

58F70VH0HS

1H-(1,3)DIOXOLO(4,5-J)PYRROLO(3,2,1-DE)PHENANTHRIDINE-1,2-DIOL, 2,4,5,7,12B,12C-HEXAHYDRO-, HYDROCHLORIDE (1:1), (1S,2S,12BS,12CS)-

C16H17NO4.HCl (323.0924)


Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2]. Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2].

   

Lycorine

1H-(1,3)DIOXOLO(4,5-J)PYRROLO(3,2,1-DE)PHENANTHRIDINE-1,2-DIOL, 2,4,5,7,12B,12C-HEXAHYDRO-, HYDROCHLORIDE (1:1), (1S,2S,12BS,12CS)-

C16H17NO4.HCl (323.0924)


Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2]. Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2].

   

Indole-3-carboxylic acid beta-D-glucopyranosyl ester

Indole-3-carboxylic acid beta-D-glucopyranosyl ester

C15H17NO7 (323.1005)


   

metazachlor ESA

metazachlor ESA

C14H17N3O4S (323.094)


An organosulfonic acid that is 2-oxoethanesulfonic acid substituted by a (2,6-dimethylphenyl)(1H-pyrazol-1-ylmethyl)amino group at position 2. It is metabolite of the herbicide metazachlor. CONFIDENCE standard compound; EAWAG_UCHEM_ID 705 CONFIDENCE standard compound; INTERNAL_ID 2061

   

Maybridge3_001181

Maybridge3_001181

C18H14FN3O2 (323.107)


   

N-{[(1-Acetylpiperidin-4-yl)carbonyl]oxy}-4-chlorobenzenecarboximidamide

N-{[(1-Acetylpiperidin-4-yl)carbonyl]oxy}-4-chlorobenzenecarboximidamide

C15H18ClN3O3 (323.1037)


   
   
   
   

(E)-N-(isoferuloyl)-glutamic acid

(E)-N-(isoferuloyl)-glutamic acid

C15H17NO7 (323.1005)


   

Entadamide A glucoside

Entadamide A glucoside

C12H21NO7S (323.1039)


   
   
   

(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)pentan-1-imine

(E)-1-(L-cysteinylglycin-S-yl)-N-hydroxy-omega-(methylsulfanyl)pentan-1-imine

C11H21N3O4S2 (323.0973)


   

Lycorine HCl

1H-(1,3)DIOXOLO(4,5-J)PYRROLO(3,2,1-DE)PHENANTHRIDINE-1,2-DIOL, 2,4,5,7,12B,12C-HEXAHYDRO-, HYDROCHLORIDE (1:1), (1S,2S,12BS,12CS)-

C16H18ClNO4 (323.0924)


Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2]. Lycorine hydrochloride is the main active ingredient of the herbal medicine derived from Lycoris radiata (L’Her.) Herb. and is also a melanoma vasculogenic inhibitor and has anti-tumor activity[1]. Lycorine hydrochloride effectively inhibits mitotic proliferation of Hey1B cells (IC50 of 1.2 μM)[2].

   

Entadamide A beta-D-glucopyranoside

Entadamide A beta-D-glucopyranoside

C12H21NO7S (323.1039)


Entadamide-A-β-D-glucopyranoside is one of the major components in the seeds of Entada phaseoloides. Entadamide-A-β-D-glucopyranoside has anti-complement activitie[1]. Entadamide-A-β-D-glucopyranoside is one of the major components in the seeds of Entada phaseoloides. Entadamide-A-β-D-glucopyranoside has anti-complement activitie[1].

   

Metazachlor-ESA

Metazachlor-ESA

C14H17N3O4S (323.094)


CONFIDENCE standard compound; INTERNAL_ID 2061

   

Ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxylate

1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester

C16H15F2NO4 (323.0969)


   
   
   
   
   
   
   
   

1-[(4-methoxy-2-nitrophenyl)azo]-2-naphthol

1-[(4-methoxy-2-nitrophenyl)azo]-2-naphthol

C17H13N3O4 (323.0906)


   

(s)-p1-(3-mercapto-1-pyrrolidinyl)ethylidene]-(4-nitrophenyl)methyl ester, carbamic acid

(s)-p1-(3-mercapto-1-pyrrolidinyl)ethylidene]-(4-nitrophenyl)methyl ester, carbamic acid

C14H17N3O4S (323.094)


   

1-PIPERIDINECARBOXYLIC ACID, 4-(5-CHLORO-2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-1-YL)-, ETHYL ESTER

1-PIPERIDINECARBOXYLIC ACID, 4-(5-CHLORO-2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-1-YL)-, ETHYL ESTER

C15H18ClN3O3 (323.1037)


   

2-methyl-1-(4-methylsulfanylphenyl)-5-phenylpyrrole-3-carboxylic acid

2-methyl-1-(4-methylsulfanylphenyl)-5-phenylpyrrole-3-carboxylic acid

C19H17NO2S (323.098)


   

1H-Indene-1,3(2H)-dione,2-benzo[f]quinolin-3-yl-

1H-Indene-1,3(2H)-dione,2-benzo[f]quinolin-3-yl-

C22H13NO2 (323.0946)


   

ethyl 2-amino-4-(biphenyl-4-yl)thiophene-3-carboxylate

ethyl 2-amino-4-(biphenyl-4-yl)thiophene-3-carboxylate

C19H17NO2S (323.098)


   

creatine citrate

creatine citrate

C10H17N3O9 (323.0965)


   

2-((6-Methoxy-2-methyl-4-quinolinyl)thio)-1-phenylethanone

2-((6-Methoxy-2-methyl-4-quinolinyl)thio)-1-phenylethanone

C19H17NO2S (323.098)


   

ETHYL 5-HYDROXY-8-ISOPROPYL-2-(METHYLTHIO)-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

ETHYL 5-HYDROXY-8-ISOPROPYL-2-(METHYLTHIO)-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

C14H17N3O4S (323.094)


   

ETHYL 5-HYDROXY-2-(METHYLTHIO)-7-OXO-8-PROPYL-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

ETHYL 5-HYDROXY-2-(METHYLTHIO)-7-OXO-8-PROPYL-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

C14H17N3O4S (323.094)


   

N-[4-(2,4,6-TRIMETHYLPHENYL)-2-THIAZOLYL]-4-PYRIDINECARBOXAMIDE

N-[4-(2,4,6-TRIMETHYLPHENYL)-2-THIAZOLYL]-4-PYRIDINECARBOXAMIDE

C18H17N3OS (323.1092)


   

Phosphonic acid, [[5-(3-fluorophenyl)-2-pyridinyl]Methyl]-, diethyl ester

Phosphonic acid, [[5-(3-fluorophenyl)-2-pyridinyl]Methyl]-, diethyl ester

C16H19FNO3P (323.1087)


   

1-Cyclopropyl-7-8-difluoro-6-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Ethyl Ester

1-Cyclopropyl-7-8-difluoro-6-Methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Ethyl Ester

C16H15F2NO4 (323.0969)


   

Cyclopentylalbendazole sulfone

Cyclopentylalbendazole sulfone

C14H17N3O4S (323.094)


   

4-(6-benzoyl-1H-benzimidazol-2-yl)benzonitrile

4-(6-benzoyl-1H-benzimidazol-2-yl)benzonitrile

C21H13N3O (323.1059)


   

(5E)-5-[4-(dimethylamino)benzylidene]-2-mercapto-3-phenyl-3,5-dihydro-4H-imidazol-4-one

(5E)-5-[4-(dimethylamino)benzylidene]-2-mercapto-3-phenyl-3,5-dihydro-4H-imidazol-4-one

C18H17N3OS (323.1092)


   

(2s, 4r)-boc-gamma-mso-proline methyl ester

(2s, 4r)-boc-gamma-mso-proline methyl ester

C12H21NO7S (323.1039)


   

Ripasudil

Ripasudil

C15H18FN3O2S (323.1104)


S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

4-Fluoro-5-((2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline

4-Fluoro-5-((2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline

C15H18FN3O2S (323.1104)


   

1-(4-Ethoxyphenyl)-3-(5-isoquinolinyl)thiourea

1-(4-Ethoxyphenyl)-3-(5-isoquinolinyl)thiourea

C18H17N3OS (323.1092)


   

2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(4-methylsulfanylbutyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid

2-[[(2R)-2-amino-3-[(E)-N-hydroxy-C-(4-methylsulfanylbutyl)carbonimidoyl]sulfanylpropanoyl]amino]acetic acid

C11H21N3O4S2 (323.0973)


   

3-Pyridinecarboxylic acid (3-acetyl-4-oxido-2-quinoxalin-4-iumyl)methyl ester

3-Pyridinecarboxylic acid (3-acetyl-4-oxido-2-quinoxalin-4-iumyl)methyl ester

C17H13N3O4 (323.0906)


   

2-(1-(Benzofuran-2-yl)ethylidene)-N-(2-methylphenyl)hydrazinecarbothioamide (3p)

2-(1-(Benzofuran-2-yl)ethylidene)-N-(2-methylphenyl)hydrazinecarbothioamide (3p)

C18H17N3OS (323.1092)


   

4-ethoxy-N-(4-fluorophenyl)-2,3-dimethylbenzenesulfonamide

4-ethoxy-N-(4-fluorophenyl)-2,3-dimethylbenzenesulfonamide

C16H18FNO3S (323.0991)


   

D-glucosyl indole-3-carboxylate

D-glucosyl indole-3-carboxylate

C15H17NO7 (323.1005)


An O-acyl carbohydrate obtained by formal condensation of the carboxy group of indole-3-carboxylic acid with the anomeric hydroxy group of D-glucose.

   

2-(5-Butylthiophen-2-yl)-2,5-dihydropyrazolo[4,3-c]quinolin-3-one

2-(5-Butylthiophen-2-yl)-2,5-dihydropyrazolo[4,3-c]quinolin-3-one

C18H17N3OS (323.1092)


   

2-[(6-chloro-2-oxo-4-propyl-1-benzopyran-7-yl)oxy]-N,N-dimethylacetamide

2-[(6-chloro-2-oxo-4-propyl-1-benzopyran-7-yl)oxy]-N,N-dimethylacetamide

C16H18ClNO4 (323.0924)


   

N-[[(4-methyl-1,2-dihydroisoquinolin-3-yl)amino]-sulfanylidenemethyl]benzamide

N-[[(4-methyl-1,2-dihydroisoquinolin-3-yl)amino]-sulfanylidenemethyl]benzamide

C18H17N3OS (323.1092)


   

5-[(4-Fluorophenyl)methylamino]-2-(2-methoxyphenyl)-4-oxazolecarbonitrile

5-[(4-Fluorophenyl)methylamino]-2-(2-methoxyphenyl)-4-oxazolecarbonitrile

C18H14FN3O2 (323.107)


   

2-Amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate

2-Amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate

C18H15N2O4- (323.1032)


   

2-(1H-benzimidazol-2-ylmethoxymethyl)-6-nitro-1H-benzimidazole

2-(1H-benzimidazol-2-ylmethoxymethyl)-6-nitro-1H-benzimidazole

C16H13N5O3 (323.1018)


   

(2-Morpholin-4-ylphenyl) 1-methylimidazole-4-sulonate

(2-Morpholin-4-ylphenyl) 1-methylimidazole-4-sulonate

C14H17N3O4S (323.094)


   
   

Phenyl-[1-(4-thieno[2,3-d]pyrimidinyl)-4-piperidinyl]methanone

Phenyl-[1-(4-thieno[2,3-d]pyrimidinyl)-4-piperidinyl]methanone

C18H17N3OS (323.1092)


   
   
   
   
   
   
   
   
   

Ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate

1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester

C16H15F2NO4 (323.0969)


   

Tazarotenic acid

Tazarotenic acid

C19H17NO2S (323.098)


   

Midaglizole (hydrochloride)

Midaglizole (hydrochloride)

C16H19Cl2N3 (323.0956)


Midaglizole hydrochloride ((±)-DG5128, DG5128) is a potent α2-adrenoceptor antagonist. Midaglizole hydrochloride is a hypoglycemic agent. Midaglizole hydrochloride increases blood pressure and reduces blood glucose levels in vivo[1][2][3]. Midaglizole hydrochloride ((±)-DG5128, DG5128) is a potent α2-adrenoceptor antagonist. Midaglizole hydrochloride is a hypoglycemic agent. Midaglizole hydrochloride increases blood pressure and reduces blood glucose levels in vivo[1][2][3].

   

TASP0415914

TASP0415914

C13H17N5O3S (323.1052)


TASP0415914 is a potent and orally active PI3Kγ inhibitor with an IC50 of 29 nM. TASP0415914 also shows potent Akt inhibitory activities with an IC50 of 294 nM. TASP0415914 can be used for inflammatory diseases research[1].

   

(2z)-3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

(2z)-3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO7S (323.1039)


   

5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)


   

(2s)-2-{[(2e)-1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

(2s)-2-{[(2e)-1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

C15H17NO7 (323.1005)


   

({5-hydroxy-2-[(1z)-2-hydroxy-2-[(e)-[(1e)-2-(4-hydroxyphenyl)ethenyl]-c-hydroxycarbonimidoyl]eth-1-en-1-yl]phenyl}imino)methyl

({5-hydroxy-2-[(1z)-2-hydroxy-2-[(e)-[(1e)-2-(4-hydroxyphenyl)ethenyl]-c-hydroxycarbonimidoyl]eth-1-en-1-yl]phenyl}imino)methyl

C18H15N2O4 (323.1032)


   

(10r)-4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

(10r)-4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)


   

4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

4,5,8-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)


   

3-(methylsulfanyl)-n-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

3-(methylsulfanyl)-n-(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO7S (323.1039)


   

3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO7S (323.1039)


   

(2s)-2-{[(2z)-1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

(2s)-2-{[(2z)-1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

C15H17NO7 (323.1005)


   

2-{[1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

2-{[1-hydroxy-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-ylidene]amino}pentanedioic acid

C15H17NO7 (323.1005)


   

(2e)-3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

(2e)-3-(methylsulfanyl)-n-(2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)prop-2-enimidic acid

C12H21NO7S (323.1039)


   

(10s)-5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

(10s)-5,8,14-trihydroxy-10-methyl-1,9,12-triazatetracyclo[9.8.0.0²,⁷.0¹³,¹⁸]nonadeca-2,4,6,8,11,13,15,17-octaen-19-one

C17H13N3O4 (323.0906)


   

(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1h-indole-3-carboxylate

(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 1h-indole-3-carboxylate

C15H17NO7 (323.1005)